Second annual: Circulating Tumour Cells

Circulating tumour cells (CTC) have been in the spotlight during the last decade with many emerging technologies for CTC detection and isolation. However, despite their clearly demonstrated prognostic value, the complexity of their biology in relation to cancer progression and metastasis is still a challenge on the path to derive predictive information from CTCs. This year’s conference will gather many experts in the field to unravel the complexity of CTC biology including the heterogeneity, microenvironment, and interactions of CTC with other immune cells which can provide important insights for therapy selection. Advances in CTC technologies will also be discussed along with the significance of CTC detection in clinical context.

More information

http://www.moleculardxeurope.com/Circulating-Tumour-Cells/